Bookrunners Citigroup Global Markets, Piper Jaffray assist with sale
By Toni Weeks
San Luis Obispo, Calif., July 13 – Anthera Pharmaceuticals, Inc. said it priced a $25 million public sale of common stock with a $3.75 million 30-day greenshoe.
The company is selling 3,333,334 common shares at $7.50 each, a 9.91% discount to the closing share price of $8.325 on July 10.
Citigroup Global Markets Inc. and Piper Jaffray & Co. are the joint bookrunning managers.
Settlement is expected July 14.
Proceeds will be used for clinical research and development and general corporate purposes.
Anthera, based in Hayward, Calif., is a biopharmaceutical company.
| Issuer: | Anthera Pharmaceuticals, Inc.
|
| Issue: | Common stock
|
| Amount: | $25 million
|
| Greenshoe: | $3.75 million, or 500,000 shares
|
| Shares: | 3,333,334
|
| Price: | $7.50
|
| Warrants: | No
|
| Joint bookrunners: | Citigroup Global Markets Inc. and Piper Jaffray & Co.
|
| Co-manager: | SunTrust Robinson Humphrey, Inc.
|
| Announcement date: | July 8
|
| Pricing date: | July 13
|
| Settlement date: | July 14
|
| Stock symbol: | Nasdaq: ANTH
|
| Stock price: | $8.325 at close July 10
|
| Market capitalization: | $292.26 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
